Today, the Generic Pharmaceutical Association (GPhA) announced that it has launched a new industry group that will educate and advocate for patient access to biosimilars. The Association said that it has launched the Biosimilars Council, a division of GPhA. The GPhA Biosimilars Council will begin operations immediately. One of its …